Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modulation of cytochrome P450-dependent eicosanoid formation by Omacor
2009-013458-33Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Sep 2009
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of omega-3-acid triglycerides (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Change in omega-3/omega-6 PUFA-derived epoxyeicosanoid ratio in erythrocytes. Started Sep 2009; status: completed.
02
Drugs
omega-3-acid triglycerides
Beyond the preview
Go deeper on 2009-013458-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013458-33.